ME Therapeutics Holdings Inc. (CSE:METX)
Canada flag Canada · Delayed Price · Currency is CAD
9.00
0.00 (0.00%)
Apr 17, 2025, 4:00 PM EDT

ME Therapeutics Holdings Income Statement

Millions CAD. Fiscal year is Sep - Aug.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022
Period Ending
Feb '25 Aug '24 Aug '23 Aug '22
Selling, General & Admin
0.430.370.360.08
Research & Development
0.270.310.030.05
Operating Expenses
1.381.370.980.15
Operating Income
-1.38-1.37-0.98-0.15
Interest Expense
-0.01--0.01-0.01
Interest & Investment Income
0.050.030.01-
Other Non Operating Income (Expenses)
0.030.05-0.02
EBT Excluding Unusual Items
-1.31-1.29-0.97-0.15
Other Unusual Items
---5.55-
Pretax Income
-1.31-1.29-6.52-0.15
Net Income
-1.31-1.29-6.52-0.15
Net Income to Common
-1.31-1.29-6.52-0.15
Shares Outstanding (Basic)
2624168
Shares Outstanding (Diluted)
2624168
Shares Change (YoY)
4.95%55.90%84.08%-
EPS (Basic)
-0.05-0.05-0.42-0.02
EPS (Diluted)
-0.05-0.05-0.42-0.02
EBITDA
-1.37-1.37-0.98-0.15
D&A For EBITDA
0.01000
EBIT
-1.38-1.37-0.98-0.15
Updated Jan 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.